Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Hims & Hers vs Loop Health

By GLP-1 ScorecardUpdated

Hims & Hers
Site position #56

Higher grade

Loop Health
Site position #271

Lower grade

Score comparison

Hims & Hers has the higher recorded score — 75.6/100 to 64.2/100.

Hims & Hers grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mass-market app-first program with nationwide reach and consumer-grade polish.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueHims & Hers +38
82
44
Dose & formulationHims & Hers +6
78
72
Clinical oversightLoop Health +24
55
79
Labs & monitoringHims & Hers +7
80
73
FulfillmentHims & Hers +6
84
78
Contract termsHims & Hers +47
80
33
Hims & Hers · top barLoop Health · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricHims & HersLoop Health
WeighScore75.6/10064.2/100
GradeCC
Site position#56#271
Semaglutide$199/mo$199/mo (all doses, microdosed, membership required, compounded)
TirzepatideNot disclosed$299/mo (all doses, microdosed, membership required, compounded)
CoverageAll 50 statesAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
Hims & Hers

Site position #56 · C

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

What to consider

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny
Loop Health

Site position #271 · C

Strengths

  • Multi-product wellness platform — GLP-1 plus peptides, NAD+, coaching, bloodwork
  • Low membership entry point ($79/mo)
  • Annual plan includes monthly 'research credit' toward compounds
  • Explicit compounded-drug FDA disclaimer on-site

What to consider

  • The medication price is on top of a $1,500-a-year membership, annual-plan only, which the terms confirm is separate from compound and medication costs
  • Everything sold here is microdosed — the banner over both products reads 'MICRODOSED GLP-1', which is not a labeled therapeutic dose
  • The prices exist only after the page's JavaScript runs; the served HTML body is empty
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard